The Centers for Disease Control and Prevention (CDC) has developed new resources to help partners fight the spread of C. auris in the U.S. and around the globe. Candida auris is an emerging, multidrug-resistant yeast that presents a serious threat to global health, causing invasive infections that can be transmitted in healthcare settings. As of August 31, 2017, a total of 153 clinical cases of C. auris infection have been reported to CDC from 10 U.S. states. An additional 143 patients have been found to be colonized with C. auris based on targeted screening.
Check out these resources to help curb C. auris in your communities:
- CDC’s auris website – Offers a one-stop site for the latest resources, guidance and surveillance data.
- A Clinical Update – Includes 5 recommendations for healthcare providers and laboratorians, including new recommendations to help identify patients colonized with auris and better control spread of C. auris.
- A call to better monitor and stop the spread of auris by increasing testing to determine Candida species.
- New research showing that auris can live for up to four weeks on surfaces in healthcare settings.
- Guidance for healthcare facilities to detect and manage auris cases and prevent transmission.